Selective C-F Bond Functionalization and Asymmetric Synthesis with Organofluorines
Project Number2R15GM106260-03
Former Number2R15GM106260-02A1
Contact PI/Project LeaderWOLF, CHRISTIAN
Awardee OrganizationGEORGETOWN UNIVERSITY
Description
Abstract Text
PROJECT ABSTRACT
The ever-increasing demand for synthetic methods that expand currently accessible chemical
space and provide efficient access to biologically active compounds has begun to shift attention
toward the development of largely unexplored Csp3-F bond functionalization chemistry. Despite
considerable progress, in particular with hydrodefluorinations, this task remains quite challenging
because the profound electron-withdrawing and stereoelectronic effects of fluorine often interfere
with established synthetic protocols and dramatically alter reaction outcomes compared to
nonfluorinated analogues. Given the abundance and diversity of readily available fluorinated
compounds, the introduction of strategies that provide control over the unique stability and
reactivity patterns of the aliphatic carbon-fluorine bond are expected to set the stage for extremely
powerful synthetic venues that streamline the production of current and future drugs.
The goals of the proposed research are to introduce new Csp3-F bond activation chemistry
that is complementary to existing methodologies by enabling unprecedented carbon-carbon and
carbon-heteroatom bond formation and an array of new synthetic opportunities with exceptional
reaction control, scope and functional group tolerance. The Csp3-F bond, typically considered
chemically inert, will become a strategically useful entity representing a latent carbon nucleophile
or electrophile, for example via unique Umpolung pathways that allow selective manipulation of
orthogonal reactivity modes, with multiple applications including late-stage functionalization. In
addition, the Csp3-F bond activation methodology will be extended to catalytic asymmetric cross-
coupling chemistry and the (organo)catalytic enantio- and diastereoselective synthesis of a variety
of multifunctional organofluorines carrying two contiguous chirality centers from the challenging
class of fluoronitriles will be pioneered.
While emphasis lies on the development of new synthetic methodologies and asymmetric
catalysis, the usefulness of the proposed transformations and reaction products in the total
synthesis of biologically active compounds will also be explored. The general feasibility and the
synthetic prospects are highlighted with ample proof-of-concept results and mechanistic insights
that underscore the broad impact of asymmetric catalysis with fluoronitriles and of strikingly
diverse C-F bond functionalization pathways which altogether will exploit organofluorines in
currently not possible ways.
Public Health Relevance Statement
PROJECT NARRATIVE
The importance of fluorinated organic chemicals in the health sciences is a result of the unique
stability of the carbon-fluoride bond and its beneficial effects on the pharmacological properties
of biologically active compounds. The synthetic potential and general utility of organofluorines,
however, are far from being fully explored. This proposal is aimed at the development of new
synthetic methodology that exploits the large variety of readily available fluoroorganic building
blocks to generate unprecedented access to multifunctional compounds and ultimately to current
and future drugs.
No Sub Projects information available for 2R15GM106260-03
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 2R15GM106260-03
Patents
No Patents information available for 2R15GM106260-03
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 2R15GM106260-03
Clinical Studies
No Clinical Studies information available for 2R15GM106260-03
News and More
Related News Releases
No news release information available for 2R15GM106260-03
History
No Historical information available for 2R15GM106260-03
Similar Projects
No Similar Projects information available for 2R15GM106260-03